MDS Podcast

Dr. Eduardo de Pablo-Fernández discusses with Prof. Tom Foltynie emerging disease-modifying and restorative treatments for Parkinson’s disease, including recent clinical trial findings and promising therapeutic approaches.

Ms. Nicole Duff discusses with Dr. Alison Yarnall the prevalence and impact of frailty in Parkinsonism, including how it is identified and measured and its implications for clinical trials and patient care.

Dr. Jerome Honnorat sits down with host Dr. Divyani Garg at the 2026 MDS international Congress to review the most recent advancements in autoimmune movement disorders.

Dr. Sabine Hilfiker addresses with Dr. Tiago Outeiro the slight differences of alpha-synuclein pathology in LRRK PD and what they could mean in terms of cell biology and molecular mechanisms.

Dr. Ignacio Mata discusses with Dr. Divyani Garg the dramatic increases in genetic testing globally over the last several years that have enhanced our understanding of the genetic architecture of Parkinson's disease.

Prof. Wassilios Meissner discusses scientific advances in multiple system atrophy,  from our growing understanding of MSA pathophysiology to potential diagnostic biomarkers to investigational therapeutics.

Prof. Burn speaks with Dr. Michele Matarazzo about the initiaves and direction of MDS.

Dr. Cecilia Peralta sits down with host Dr. Michele Matarazzo to review the most recent findings and future of neuroimaging in the field.

Dr. Genko Oyama gives us an inside look at the most exciting moments from the last full day of the MDS Congress — including 2 exciting Clinical Breakthrough announcements and his favorite case from the Video Challenge.

Dr. Andrew Siderowf shares what you missed from #mdscongress day three, which included a deep dive into the evolving AI landscape and insightful live patient rounds.